Physical symptoms are the most common reason patients seek medical attention. Despite medical advances, up to a third remain unexplained, even after extensive evaluation.
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Fortunately, most patients with medically unexplained symptoms experience symptom resolution, 2 although a subset of patients' symptoms persists. The number, severity, and functional impact of patient symptoms likely represents a continuum from the small proportion of patients meeting DSM-IV criteria for somatization disorder to the many patients with persistent symptoms who do not have somatization disorder but nonetheless have considerable impairment. Previously, management of such patients was reactive rather than proactive, and largely based on limiting care. Clinicians negotiated and tried to optimize visit frequency and limit diagnostic testing and referrals for stable symptoms. Symptoms were treated symptomatically, usually with limited success. Both clinicians and patients were frustrated by this process and patients often left to seek other ''better'' advice. The trial by Smith et al. is unique for 2 reasons. First, it tackles symptoms as a broad class, rather than limiting itself to a specific symptom syndrome. Second, it is the first randomized-controlled trial of treating high-utilizing patients with medically unexplained symptoms. Clinicians will heartily appreciate trial data to help them do more for their patients than just minimize visits, testing, and referrals.
In this trial, patients were randomized to usual versus augmented care in which nurse practitioners used patientcentered methods to establish good patient-provider relationships and to inform and motivate patients about treatment. A variety of treatment modalities were available including antidepressants, reduction/elimination of ineffective-controlled substances, exercise, relaxation training, physical therapy, comorbid disease management, and referrals, mostly to mental health professionals. Patients were scheduled to be seen 12 times over the 1-year trial, with telephone contact available between visits. The primary study outcome measure was change in the mental composite score of the SF-36, and the authors found an absolute 14% improvement (48% improved vs 34% improved) among those receiving the intervention, compared with those who did not. Other improved outcomes included depression and disability scores, as well as satisfaction. Patients in the intervention group were more likely to reduce narcotic use and be on full-dose antidepressants.
The findings by Smith et al. prompt a brief consideration of 9 issues related to somatization per se as well as some analogies with chronic medical disorders.
(1) Multicomponent interventions: The treatment program for MUS was a bundled one, making it difficult to disentangle specific components. The most important mediator of improvement in mental health and disability indices appeared to be the use of full-dose antidepressants, but as the authors rightly point out, this is an achievement in itself, as this can be difficult to accomplish in this patient population. Improved satisfaction seemed more clearly due to the change in clinician-patient communication. ''reattribution'' has proven to an effective therapy for some somatizing patients in primary care. 4, 5 Third, the directionality of the relationship between physical and psychological symptoms is often indeterminate: for example, is chronic pain the consequence or the cause of concomitant depression or are the 2 conditions the products of a common pathway? Fourth, even when physical symptoms respond to ''psychological'' treatments such as antidepressants or CBT, the effect size may be less than that seen for depression. 3, 6, 7 Finally, antidepressants may be beneficial for physical symptoms, even among patients without depression. 3 Axonal projections of serotonin and norepinephrine, may mediate depressive symptoms: frontal cortex projections may regulate mood and cognition; hypothalamic projections may affect appetite, pleasure, and sex drive; limbic regions affect emotions and anxiety; and basal ganglia projections affect psychomotor function. Many of these brain areas have abnormal activity among patients with symptom syndromes. 8 In addition, both serotonin and norepinephrine may exert analgesic effects via inhibitory descending pain randomized trials to alter communication in order to improve patients' health and well being and found that a range of approaches could achieve changes in this interaction, and some show promise in improving patients' health. However, health outcomes were rarely measured objectively and only 4 trials with health outcomes met predefined quality criteria.
(7)
Negative clinician attitudes. The presence of depression or anxiety in a patient makes it 3 times more likely the clinician will perceive the medical encounter as difficult, and somatization increases this likelihood 9-fold. 19 Moreover, neither mental health nor medical specialists are particularly desirous of treating somatizing patients, gladly relinquishing this care to the primary care clinician. At the same time, having sole responsibility for complex MUS contributes to career dissatisfaction among generalist physicians. 20 Given their prevalence in specialty settings, 21 MUS should be in the core curriculum of every residency and fellowship program, and shared care of MUS should be the responsibility of every provider. (8) Locus of therapy and reimbursement. In some socialized health care systems, generalist physicians have been trained to provide brief psychosocial interventions for somatizing patients. 16, 24 However, treatments that require talking with patients are economically disadvantaged in the current U.S. system which reimburses technological procedures far more than patient-provider communication. Indeed, even E&M documentation requirements favor examining rather than talking to the patient, even though the latter is more diagnostically informative and therapeutic. 1 While delivery of psychosocial interventions by nurses or other health care professionals as in the trial by Smith is another strategy, paying for this is problematic. Mental health referral is a third option but access to those trained in somatically focused CBT is limited. Moreover, patients who attribute their MUS to physical disorders are frequently reluctant to see a mental health specialist. Stepped care approaches with the primary care physician providing care for most of the patients but assisted by care managers and specialists for more complex cases is probably the optimal strategy for treating MUS. (9) Salient outcomes. In the words of Joan Didion, a modern writer and migraineur: ''The actual headache, when it comes, brings with it chills, sweating, nausea, a debility that seems to stretch the very limits of endurance. That no one dies of migraine seems, to someone deep into an attack, an ambiguous blessing.'' Although death is an unlikely consequence, other D's relevant to MUS include disability, discomfort, dissatisfaction, and ''destitution,'' i.e., the considerable medical costs resulting from somatization. For these reasons, medically unexplained symptoms should not be synonymous with medically ignored.
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